Afghanistan's narcotics problems grow worse

By R. Jeffrey Smith and Mattie Quinn

A costly and ambitious U.S. effort to curtail Afghanistan's poppy production falters as U.S. forces draw down.

Excerpts from this story referencing "Afghanistan":

"… t sweeping goals for U.S. financial, military, and technical assistance to Afghanistan, including developing an economy there “that isn’t dominated by illici …"

"… o years, all that spending appears to have had little enduring impact, and Afghanistan’s prospects for finding its fiscal footing outside the drug trade are no …"

"… Caucus on International Narcotics Control on Jan. 15. “The situation in Afghanistan is dire with little prospect for improvement in 2014 or beyond,” Special …"

"… ospect for improvement in 2014 or beyond,” Special Inspector General for Afghanistan Reconstruction John F. Sopko told the caucus, recounting “the opinion of …"

OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "Pharmaceutical Research and Manufacturers of America":

"… D. Bennett, senior vice president of communications and public affairs at Pharmaceutical Research and Manufacturers of America (PhRMA), wrote within hours of the speech: “The President’s proposal …"

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "Virginia":

"… have included Washington D.C. Mayor Vincent Gray and U.S. Sen. Jim Webb of Virginia.Press officials at PhRMA declined to answer questions about the contributi …"

Panel recommends new agency to investigate safety of health information technology

By Kimberly Leonard

Institute of Medicine panel recommends new regulatory body, not FDA

Excerpts from this story referencing "National Transportation Safety Board":

"… create and fund a new independent watchdog agency, along the lines of the National Transportation Safety Board. Like NTSB, the new agency would conduct investigations and make recommend …"

Overmedicating young Louisiana inmates

By Matt Davis

Incarcerated youths in Louisiana are receiving powerful drugs even when their conditions don't call for it

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

Feds have done little to contain genetically modified animals and plants

By Laurel Adams

Government has done little to ensure genetically modified animals and plants don't escape into wild

$1 billion for anti-narco programs, and no central database to track it

By Laurel Adams

State Department doesn't have a central tracking mechanism for its $1 billion counter-narcotics programs

Excerpts from this story referencing "Peru":

"… f State’s $1 billion supports programs in Mexico, Afghanistan, Colombia, Peru and Bolivia. The Bureau of International Narcotics and Law Enforcement Aff …"

"… ombia, $281 million to Afghanistan, $249 million to Mexico, $69 million to Peru and $39 million to Bolivia for State’s counter-narcotics efforts. …"

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

Excerpts from this story referencing "Chile":

"… in fish farms abroad. In 2009, emamectin benzoate was found in salmon from Chile that was already accepted for import in the U.S. There is additional conce …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "Drug Enforcement Administration":

"… t,” he said.Mark Caverly, chief of the liaison and policy section of the Drug Enforcement Administration’s Office of Diversion Control, said the root of the problem probably res …"

"… ier directory is available. For a fee, net surfers can also gain access to Drug Enforcement Administration prescriber numbers from a website run by a private company in partnership …"

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

FDA asks hospitals to report safety glitches in digital health systems

By Fred Schulte and Emma Schwartz

In letter to 350 health centers, agency signals growing concern

FDA considers regulating safety of electronic health systems

By Fred Schulte and Emma Schwartz

Reports of patient harm include six deaths in two years

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

Major gaps in oversight of human medical research

By Jeanne Lenzer and Shannon Brownlee

Columbia Hospital case a cautionary tale

Excerpts from this story referencing "Columbia":

"… ient consent.Now details have surfaced about a clinical trial at Columbia University Medical Center that took place not long after the Gelsinge …"

"… at was the legacy of the teen’s death.Federal regulators have cited Columbia for ethical and regulatory mistakes in a clinical trial, completed in 2001 …"

"… ow have concluded that some patients may have been harmed and have ordered Columbia to track down all participants to inform them of the facts of the study an …"

"… medical problems.If the Gelsinger case was a pivotal moment in reform, the Columbia case is a cautionary tale, coming to light months after a sobering nationa …"

Government orders Columbia to tell patients 'true nature' of drug study

By Jeanne Lenzer and Shannon Brownlee

Officials say research may have caused harm to people who had heart surgery

ATF’s ‘ad hoc’ efforts give tobacco smugglers a free pass

By Te-Ping Chen

Smuggling cigarettes in America has become a multi-billion-dollar business, robbing states of desperately needed tax money and fueling organ

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Excerpts from this story referencing "Peru":

"… ites in countries that include the United States, Canada, Ukraine, Mexico, Peru, and Colombia to take Celebrex, naproxen, or ibuprofen. Neither patients n …"

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "UCLA":

"… tside experts remain concerned. Jerome Hoffman, a professor of medicine at UCLA, noted that not all of the reported AERS deaths occurred after the recall. …"

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

Excerpts from this story referencing "Government Accountability Office":

"… in the wake of the globalization of the pharmaceutical supply chain. The Government Accountability Office (GAO) called for improvement in the FDA’s Foreign Drug Inspection Progra …"

Problems in oversight of food safety

By The Center for Public Integrity

Food safety oversight agencies often inconsistent and ineffective, says GAO

Excerpts from this story referencing "Illinois":

"… . . too often proves them wrong,” said Democratic Senator Dick Durbin of Illinois. The GAO has called for a fundamental re-examination of the food safety sy …"

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

The expert: watch an interview with Luk Joossens


Watch an interview with Luk Joossens

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation